| Entity Name: | Tetraphase Pharmaceuticals, Inc. |
| Jurisdiction: | Connecticut |
| Legal type: | Stock |
| Citizenship: | Foreign |
| Status: | Active |
| Date Formed: | 07 Jun 2023 (Companies founded in June 2023) |
| Business ALEI: | 2718634 |
| Annual report due: | 07 Jun 2025 |
| NAICS code: | 541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| Business address: | 35 Gatehouse Drive, Waltham, MA, 02451, United States |
| Mailing address: | 35 Gatehouse Drive, Waltham, MA, United States, 02451 |
| Place of Formation: | DELAWARE |
| E-Mail: | compliance@istx.com |
| Name | Role |
|---|---|
| C T CORPORATION SYSTEM | Agent |
| Name | Role | Business address | Residence address |
|---|---|---|---|
| Matthew Ronsheim | Officer | 35 Gatehouse Dr, Waltham, MA, 02451-1215, United States | 35 Gatehouse Dr, Waltham, MA, 02451-1215, United States |
| Filing number | Filing date | Effective date | Filing category | Filing type | Report year |
|---|---|---|---|---|---|
| BF-0012062151 | 2024-05-08 | No data | Annual Report | Annual Report | No data |
| BF-0011768254 | 2023-06-07 | No data | Business Registration | Certificate of Authority | No data |
Date of last update: 11 Nov 2024
Sources: Connecticut's Official State Website
